DOJ, SEC Investigating GlaxoSmithKline for Possible FCPA Violations

GSK is one of at least six pharmaceutical giants to receive letters of inquiry from the Justice Department and the Securities and Exchange Commission.

Get unlimited access to all Global Investigations Review content